- Ludovic Couturier, IDIT
- Yann Menon, EUSAPHARMA
Frédéric LETACQ, Research Engineer – IDIT (International Institute of Transport Law)
Yann MENON, Logistics Coordinator – EUSAPHARMA Laboratory
Jean-Philippe BRILLAND, BOLLORE LOGISTICS
Henrik Larsen, Business Development Manager – MTS Logistics Ltd
Laurence COREDO, Assistant to the Interregional Director of Customs of Normandy – CUSTOMS
After a presentation on the legal and regulatory consequences of Brexit and the Agreements to be considered to maintain trade relations between the EU and the UK, a round table on practical difficulties and risks will allow the professionals involved to express their views.
What are the legal and regulatory consequences?
What are the risks and options for pharmaceutical products in terms of access to the transport market?
How did the Customs administration prepare itself?
14h00 – 14h10 : Context and legal consequences of the BREXIT Intervention: Frédéric LETACQ, IDIT Research Engineer
14h10 – 14h30 : Measures implemented by Customs Laurence COREDO, Assistant to the Interregional Director of Customs in Normandy – CUSTOMS
14h30 – 14h40 : BREXIT risks – Perspective of a pharmaceutical laboratory Intervention : Yann MENON, Logistics Coordinator – EUSAPHARMA
14h40 – 14h50 : Point of view of a transport commissioner Intervention : Jean-Philippe BRILLAND – BOLLORE LOGISTICS
14h50 – 15h00 : Point of view of an English carrier Intervention : Henrik Larsen, Business Development Manager – MTS Logistics Ltd
15h00 – 15h30 : Exchanges